SOTYKTU

bristol-myers squibb canada🇨🇦 Health Canada

Approval Id: 2c18f5ebbf859525
Drug Approval Canada Name: SOTYKTU
Product Name: SOTYKTU
Status: Marketed
Status Date: 2023-02-14
Original Market Date: 2023-02-14
Din: 02533030
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 84:06.16
Atc Original: L04AF07 DEUCRAVACITINIB
Atc Name: l 04 af 07
Aig Number: 0164321001
Company Name: bristol-myers squibb canada
Company Address: 2344 Boul. Alfred-Nobel, Suite 300, St-Laurent, Quebec, Canada, H4S 0A4

DEUCRAVACITINIB

6 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2c18f5ebbf859525

Type

Standard